AnGes Valuation

AMGXF Stock  USD 0.36  0.00  0.00%   
AnGes seems to be overvalued based on Macroaxis valuation methodology. Our model approximates the value of AnGes Inc from examining the firm fundamentals such as Shares Outstanding of 156.07 M, return on equity of -0.43, and Operating Margin of (243.51) % as well as analyzing its technical indicators and probability of bankruptcy. . In general, most investors favor locking in undervalued instruments and disposing overvalued instruments since, at some point in time, asset prices and their ongoing real values will blend.
Overvalued
Today
0.36
Please note that AnGes' price fluctuation is extremely dangerous at this time. Calculation of the real value of AnGes Inc is based on 3 months time horizon. Increasing AnGes' time horizon generally increases the accuracy of value calculation and significantly improves the predictive power of the methodology used.
The fair value of the AnGes otc stock is determined by what a typical buyer is willing to pay for full or partial control of AnGes Inc. Since AnGes is currently traded on the exchange, buyers and sellers on that exchange determine the market value of AnGes OTC Stock. However, AnGes' intrinsic value may or may not be the same as its current market price, in which case there is an opportunity to profit from the mispricing, assuming the market price will eventually merge with its intrinsic value.
Historical Market  0.36 Real  0.31 Hype  0.36 Naive  0.37
The real value of AnGes OTC Stock, also known as its intrinsic value, is the underlying worth of AnGes Inc OTC Stock, which is reflected in its stock price. It is based on AnGes' financial performance, growth prospects, management team, or industry conditions. The intrinsic value of AnGes' stock can be calculated using various methods such as discounted cash flow analysis, price-to-earnings ratio, or price-to-book ratio. That value may differ from its current market price, which is determined by supply and demand factors such as investor sentiment, market trends, or news.
0.31
Real Value
1.88
Upside
Estimating the potential upside or downside of AnGes Inc helps investors to forecast how AnGes otc stock's addition to their portfolios will impact the overall performance. We also use other valuation drivers to help us estimate the true value of AnGes more accurately as focusing exclusively on AnGes' fundamentals will not take into account other important factors:
Bollinger
Band Projection (param)
LowerMiddle BandUpper
0.360.360.36
Details
Hype
Prediction
LowEstimatedHigh
0.020.361.93
Details
Naive
Forecast
LowNext ValueHigh
0.010.371.95
Details

AnGes Total Value Analysis

AnGes Inc is presently anticipated to have takeover price of 78.35 M with market capitalization of 159.2 M, debt of 0, and cash on hands of 13.21 B. Please note that takeover price may be misleading and is a subject to mistakes in financial statements. We encourage investors to thoroughly investigate all of the AnGes fundamentals before making investing decisions based on enterprise value of the company

AnGes Investor Information

The company has price-to-book (P/B) ratio of 0.73. Some equities with similar Price to Book (P/B) outperform the market in the long run. AnGes Inc recorded a loss per share of 0.65. The entity had not issued any dividends in recent years. Based on the key indicators related to AnGes' liquidity, profitability, solvency, and operating efficiency, AnGes Inc is not in a good financial situation at the moment. It has a very high risk of going through financial straits in March.

AnGes Asset Utilization

The asset utilization indicator refers to the revenue earned for every dollar of assets a company currently reports. AnGes has an asset utilization ratio of 0.14 percent. This implies that the OTC Stock is making $0.001411 for each dollar of assets. An increasing asset utilization means that AnGes Inc is more efficient with each dollar of assets it utilizes for everyday operations.

AnGes Ownership Allocation

AnGes holds a total of 156.07 Million outstanding shares. Almost 93.25 percent of AnGes outstanding shares are held by general public with 1.66 (percent) owned by insiders and only 5.09 % by other corporate entities. Please note that no matter how many assets the company secures, if the real value of the firm is less than the current market value, you may not be able to make money on it.

AnGes Profitability Analysis

The company reported the revenue of 64.15 M. Net Loss for the year was (13.68 B) with loss before overhead, payroll, taxes, and interest of (26 M).
Please note that valuation analysis is one of the essential comprehensive assessments in business. It evaluates AnGes' worth, which you can determine by considering its current assets, liabilities and future cash flows. The investors' valuation analysis is an important metric that will give you a perspective on different companies. It helps you know the worth of the potential investment in AnGes and how it compares across the competition.

About AnGes Valuation

The otc valuation mechanism determines AnGes' current worth on a weekly basis. Our valuation model uses a comparative analysis of AnGes. We calculate exposure to AnGes's market risk, different technical and fundamental indicators, and relevant financial multiples and ratios and then compare them to those of AnGes's related companies.
AnGes, Inc., a biopharmaceutical company, engages in the research and development of gene-based medical products. AnGes, Inc. was founded in 1999 and is headquartered in Ibaraki, Japan. Anges Mg is traded on OTC Exchange in the United States.

8 Steps to conduct AnGes' Valuation Analysis

OTC Stock's valuation is the process of determining the worth of any otc stock in monetary terms. It estimates AnGes' potential worth based on factors such as financial performance, market conditions, growth prospects, and overall economic environment. The result of otc stock valuation is a single number representing a OTC Stock's current market value. This value can be used as a benchmark for various financial transactions such as mergers and acquisitions, initial public offerings (IPOs), or private equity investments. To conduct AnGes' valuation analysis, follow these 8 steps:
  • Gather financial information: Obtain AnGes' financial statements, including balance sheets, income statements, and cash flow statements.
  • Determine AnGes' revenue streams: Identify AnGes' primary sources of revenue, including products or services offered, target markets, and pricing strategies.
  • Analyze market data: Research AnGes' industry and market trends, including the size of the market, growth rate, and competition.
  • Establish AnGes' growth potential: Evaluate AnGes' management, business model, and growth potential.
  • Determine AnGes' financial performance: Analyze its financial statements to assess its historical performance and future potential.
  • Choose a valuation method: Consider the OTC Stock's specific circumstances and choose an appropriate valuation method, such as the discounted cash flow (DCF) or comparable analysis method.
  • Calculate the value: Apply the chosen valuation method to the financial information and market data to calculate AnGes' estimated value.
  • Review and adjust: Review the results and make necessary adjustments, considering any relevant factors that may have been missed or overlooked.
Note: This is a general outline, and different approaches and methods may be used depending on the type and size of the otc stock being valued. We also recomment to seek professional assistance to ensure accuracy.

AnGes Growth Indicators

Investing in growth stocks can be very risky. If the company such as AnGes does not do well, investors take a loss on the stock when it is time to sell. Also, because growth stocks typically do not pay dividends, the only opportunity an investor has to make money on their investment is when they eventually sell their shares.
Common Stock Shares Outstanding153.1 M
Retained Earnings-12.4 B
Shares Float162.1 M

Complementary Tools for AnGes OTC Stock analysis

When running AnGes' price analysis, check to measure AnGes' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy AnGes is operating at the current time. Most of AnGes' value examination focuses on studying past and present price action to predict the probability of AnGes' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move AnGes' price. Additionally, you may evaluate how the addition of AnGes to your portfolios can decrease your overall portfolio volatility.
Performance Analysis
Check effects of mean-variance optimization against your current asset allocation
Odds Of Bankruptcy
Get analysis of equity chance of financial distress in the next 2 years
Money Flow Index
Determine momentum by analyzing Money Flow Index and other technical indicators
AI Portfolio Architect
Use AI to generate optimal portfolios and find profitable investment opportunities
Economic Indicators
Top statistical indicators that provide insights into how an economy is performing